New Current Report Filed with the SEC Relating to Statement that Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review Should Not Be Relied Upon: 8-K – ELITE PHARMACEUTICALS INC /NV/ (0001053369) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) relating to a statement that certain of the company’s previously-issued financial statements or a related audit report or completed interim review should not be relied upon by investors or other interested parties. Details of the current report are:

8-K – ELITE PHARMACEUTICALS INC /NV/ (0001053369) (Filer)
Filed: 2015-12-04 AccNo: 0001144204-15-069392 Size: 39 KB

Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Filing Date: 2015-12-04T16:30:28-05:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/1053369/000114420415069392/0001144204-15-069392-index.htm